JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB25336

Anti-TCR alpha + TCR beta antibody [H57-597]

Be the first to review this product! Submit a review

|

(10 Publications)

Armenian hamster Monoclonal TCA antibody. Suitable for IP, Flow Cyt, IF, IHC-Fr and reacts with Mouse samples. Cited in 10 publications. Immunogen corresponding to Synthetic Peptide within Mouse Trac.

View Alternative Names

T-cell receptor alpha chain constant, Trac

  • 519 FITC

    FITC Anti-TCR alpha + TCR beta antibody [H57-597]

Key facts

Host species

Armenian hamster

Clonality

Monoclonal

Clone number

H57-597

Isotype

IgG

Carrier free

No

Reacts with

Mouse

Applications

IHC-Fr, IF, IP, Flow Cyt

applications

Immunogen

Synthetic Peptide within Mouse Trac. The exact immunogen used to generate this antibody is proprietary information.

P01849

Specificity

ab25336 reacts with a common epitope of the ß chain of the mouse aß T cell receptor (TCR) complex.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "IF" : {"fullname" : "Immunofluorescence", "shortname":"IF"}, "IHCFr" : {"fullname" : "Immunohistochemistry (Frozen sections)", "shortname":"IHC-Fr"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "guaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "IF-species-checked": "guaranteed", "IF-species-dilution-info": "", "IF-species-notes": "<p></p>", "IHCFr-species-checked": "guaranteed", "IHCFr-species-dilution-info": "", "IHCFr-species-notes": "<p></p>" } } }

Product details

ab25336 does not react with yd TCR-bearing cells. Plate-bound or soluble ab25336 activates aß TCR-bearing T cells. In vitro and in vivo, ab25336 can induce immature thymocytes to undergo apoptosis. In vivo administration of ab25336 has been shown to deplete aß TCR-bearing cells to near completion and prevent graft rejection.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification
Purification notes
Purified from tissue culture supernatant
Storage buffer
pH: 7.2 Preservative: 0.09% Sodium azide Constituents: 0.87% Sodium chloride, 0.14% Sodium dihydrogen phosphate
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The T-cell receptor (TCR) alpha and TCR beta sometimes referred to as alpha beta TCR or alfa TCR are essential components of the immune response machinery. TCR alpha and beta chains each have a mass that varies between 30-40 kDa depending on the variable region's length. These receptor chains are expressed on the surface of T-cells more specifically on the vast majority of T lymphocytes and play a critical role in antigen recognition. Commercial names like anti-TCR or H57 might refer to antibodies targeting these chains.
Biological function summary

TCR alpha and beta chains form a heterodimeric complex with other important proteins like CD3 to transmit signals inside the T-cell upon antigen binding. This complex becomes active when T-cells recognize peptide antigens presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells. The interaction between TCR and MHC-peptide complex initializes T-cell activation and subsequent immune responses being central to adaptive immunity.

Pathways

TCR alpha and beta are integral to the T-cell receptor signaling pathway. This pathway facilitates the activation of important transcription factors such as NF-kB and AP-1 which drive T-cell proliferation and differentiation. The signaling involves several other proteins such as protein kinase C theta and ZAP-70 which further propagate intracellular signaling cascades essential for a fully functional immune response.

Mutations or malfunctions in TCR alpha and beta chains can associate with autoimmune disorders like rheumatoid arthritis and certain types of immunodeficiency. Rheumatoid arthritis involves aberrant TCR signaling pathways that result in inappropriate immune responses against self-antigens. In some immunodeficiencies defective TCR signaling impairs T-cell development and function potentially involving related proteins like CD3 and ZAP-70 leading to compromised immune defenses.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Constant region of T cell receptor (TR) alpha chain. Alpha-beta T cell receptors are antigen specific receptors which are essential to the immune response and are present on the cell surface of T lymphocytes. Recognize peptide-major histocompatibility (MH) (pMH) complexes that are displayed by antigen presenting cells (APC), a prerequisite for efficient T cell adaptive immunity against pathogens. Binding of alpha-beta TR to pMH complex initiates TR-CD3 clustering on the cell surface and intracellular activation of LCK that phosphorylates the ITAM motifs of CD3G, CD3D, CD3E and CD247 enabling the recruitment of ZAP70. In turn, ZAP70 phosphorylates LAT, which recruits numerous signaling molecules to form the LAT signalosome. The LAT signalosome propagates signal branching to three major signaling pathways, the calcium, the mitogen-activated protein kinase (MAPK) kinase and the nuclear factor NF-kappa-B (NF-kB) pathways, leading to the mobilization of transcription factors that are critical for gene expression and essential for T cell growth and differentiation. The T cell repertoire is generated in the thymus, by V-(D)-J rearrangement. This repertoire is then shaped by intrathymic selection events to generate a peripheral T cell pool of self-MH restricted, non-autoaggressive T cells. Post-thymic interaction of alpha-beta TR with the pMH complexes shapes TR structural and functional avidity.
See full target information Trac

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Investigative ophthalmology & visual science 61:18 PubMed33320171

2020

T and B Lymphocyte Deficiency in Rag1-/- Mice Reduces Retinal Ganglion Cell Loss in Experimental Glaucoma.

Applications

Unspecified application

Species

Unspecified reactive species

Oliver W Gramlich,Cheyanne R Godwin,Neal D Heuss,Dale S Gregerson,Markus H Kuehn

Frontiers in immunology 9:78 PubMed29434598

2018

Core Fucosylation of the T Cell Receptor Is Required for T Cell Activation.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Liang,Shanshan Mao,Shijie Sun,Ming Li,Zhi Li,Rui Yu,Tonghui Ma,Jianguo Gu,Jianing Zhang,Naoyuki Taniguchi,Wenzhe Li

International immunology 3:1005-13 PubMed1661605

1991

Failure of T cell receptor V beta negative selection in murine intestinal intra-epithelial lymphocytes.

Applications

Unspecified application

Species

Unspecified reactive species

S Murosaki,Y Yoshikai,A Ishida,T Nakamura,G Matsuzaki,H Takimoto,H Yuuki,K Nomoto

Journal of immunology (Baltimore, Md. : 1950) 146:3340-6 PubMed1827483

1991

In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Y F Shi,R P Bissonnette,N Parfrey,M Szalay,R T Kubo,D R Green

Cell 58:1047-54 PubMed2673539

1989

The thymus has two functionally distinct populations of immature alpha beta + T cells: one population is deleted by ligation of alpha beta TCR.

Applications

Unspecified application

Species

Unspecified reactive species

T H Finkel,J C Cambier,R T Kubo,W K Born,P Marrack,J W Kappler

Journal of immunology (Baltimore, Md. : 1950) 142:3917-22 PubMed2469727

1989

A common epitope on human myelin basic protein and the human T lymphocyte CD3 molecule.

Applications

Unspecified application

Species

Unspecified reactive species

J W Zhang,W E Weber,J Borst,A A Vandenbark,J C Raus

Journal of immunology (Baltimore, Md. : 1950) 142:3909-12 PubMed2785569

1989

Antisera to the secretory component recognize the murine Fc receptor for IgA.

Applications

Unspecified application

Species

Unspecified reactive species

S S Crago,C J Word,T B Tomasi

Journal of immunology (Baltimore, Md. : 1950) 142:3006-12 PubMed2523422

1989

Alpha beta T cell receptor and CD3 transduce different signals in immature T cells. Implications for selection and tolerance.

Applications

Unspecified application

Species

Unspecified reactive species

T H Finkel,P Marrack,J W Kappler,R T Kubo,J C Cambier

Journal of immunology (Baltimore, Md. : 1950) 142:2736-42 PubMed2467936

1989

Characterization of a monoclonal antibody which detects all murine alpha beta T cell receptors.

Applications

Unspecified application

Species

Unspecified reactive species

R T Kubo,W Born,J W Kappler,P Marrack,M Pigeon

International immunology 1:29-35 PubMed2577287

1989

Virgin and memory T cells have different requirements for activation via the CD2 molecule.

Applications

Unspecified application

Species

Unspecified reactive species

J A Byrne,J L Butler,E L Reinherz,M D Cooper
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com